<DOC>
	<DOCNO>NCT02221505</DOCNO>
	<brief_summary>LOP628 antibody-drug conjugate ( ADC ) consist anti-cKit humanize IgG1/Îº antibody conjugate maytansine payload via non-cleavable linker . LOP628 provide opportunity target cKit overexpressing tumor .</brief_summary>
	<brief_title>Phase 1 Study LOP628 Adult Patients With cKit-positive Solid Tumors Acute Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>For patient solid tumor : document cKitpositive neoplasms Patient must progressive disease define follow : SCLC : patient progress least 1 prior therapy GIST : patient relapse refractory disease , approve effective therapeutic option exist Patients cKitpositive solid tumor : patient progress least one prior line therapy approve effective therapeutic option exist Patient measurable disease per RECIST v1.1 criterion For patient AML : document cKitpositive acute myelogenous leukemia Consent newly obtain bone marrow aspirate Patient must progressive disease define relapsed refractory nonPML AML follow standard therapy effective therapy exists . Blast count &lt; 50,000/mm3 For patient solid tumor : Patient central nervous system ( CNS ) metastatic involvement unless CNS metastases previously treat patient clinically stable stable dose corticosteroid least 4 week prior enrollment . Patient presence clinically significant hematologic , cardiac , respiratory , gastrointestinal , renal , hepatic neurological condition . Patient history serious allergic reaction , opinion investigator may pose increase risk serious infusion reaction Patient previously treat cKit direct antibody Pregnant nursing woman For patient AML : Patient receive prior allogeneic bone marrow transplant ( BMT ) . Patient presence clinically significant cardiac , respiratory , gastrointestinal , renal , hepatic neurological disease Patient history serious allergic reaction , opinion investigator may pose increase risk serious infusion reaction Patient previously treat cKit direct antibody Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>LOP628 ,</keyword>
	<keyword>cKit ,</keyword>
	<keyword>ADC ,</keyword>
	<keyword>Antibody drug conjugate ,</keyword>
	<keyword>maytansine</keyword>
</DOC>